136 related articles for article (PubMed ID: 30794858)
1. Anti-cancer effect of Indanone-based thiazolyl hydrazone derivative on colon cancer cell lines.
Narayanan S; Gupta P; Nazim U; Ali M; Karadkhelkar N; Ahmad M; Chen ZS
Int J Biochem Cell Biol; 2019 May; 110():21-28. PubMed ID: 30794858
[TBL] [Abstract][Full Text] [Related]
2. Anticancer effect of Indanone-based thiazolyl hydrazone derivative on p53 mutant colorectal cancer cell lines: An
Narayanan S; Teng QX; Wu ZX; Nazim U; Karadkhelkar N; Acharekar N; Yoganathan S; Mansoor N; Ping FF; Chen ZS
Front Oncol; 2022; 12():949868. PubMed ID: 35992866
[TBL] [Abstract][Full Text] [Related]
3. Anticancer activity of gallic acid template-based benzylidene indanone derivative as microtubule destabilizer.
Singh A; Fatima K; Srivastava A; Khwaja S; Priya D; Singh A; Mahajan G; Alam S; Saxena AK; Mondhe DM; Luqman S; Chanda D; Khan F; Negi AS
Chem Biol Drug Des; 2016 Nov; 88(5):625-634. PubMed ID: 27495835
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of imidazo[2,1-b]thiazole-chalcone conjugates: microtubule-destabilizing agents.
Kamal A; Balakrishna M; Nayak VL; Shaik TB; Faazil S; Nimbarte VD
ChemMedChem; 2014 Dec; 9(12):2766-80. PubMed ID: 25313981
[TBL] [Abstract][Full Text] [Related]
5. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
Kassab AE; Hassan RA
Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and anticancer properties of IsoCombretaQuinolines as potent tubulin assembly inhibitors.
Khelifi I; Naret T; Renko D; Hamze A; Bernadat G; Bignon J; Lenoir C; Dubois J; Brion JD; Provot O; Alami M
Eur J Med Chem; 2017 Feb; 127():1025-1034. PubMed ID: 28166995
[TBL] [Abstract][Full Text] [Related]
7. [1,2]Oxazolo[5,4-e]isoindoles as promising tubulin polymerization inhibitors.
Spanò V; Pennati M; Parrino B; Carbone A; Montalbano A; Lopergolo A; Zuco V; Cominetti D; Diana P; Cirrincione G; Zaffaroni N; Barraja P
Eur J Med Chem; 2016 Nov; 124():840-851. PubMed ID: 27643641
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of bis(indolyl)ketohydrazide-hydrazones: Identification of potent and selective novel tubulin inhibitors.
Tantak MP; Klingler L; Arun V; Kumar A; Sadana R; Kumar D
Eur J Med Chem; 2017 Aug; 136():184-194. PubMed ID: 28494255
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphene suppresses growth of colon cancer-derived tumors via induction of glutathione depletion and microtubule depolymerization.
Byun S; Shin SH; Park J; Lim S; Lee E; Lee C; Sung D; Farrand L; Lee SR; Kim KH; Dong Z; Lee SW; Lee KW
Mol Nutr Food Res; 2016 May; 60(5):1068-78. PubMed ID: 26918318
[TBL] [Abstract][Full Text] [Related]
10. Discovery of tertiary amide derivatives incorporating benzothiazole moiety as anti-gastric cancer agents in vitro via inhibiting tubulin polymerization and activating the Hippo signaling pathway.
Song J; Gao QL; Wu BW; Zhu T; Cui XX; Jin CJ; Wang SY; Wang SH; Fu DJ; Liu HM; Zhang SY; Zhang YB; Li YC
Eur J Med Chem; 2020 Oct; 203():112618. PubMed ID: 32682200
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, antitumor activity and mechanism of action of novel 1,3-thiazole derivatives containing hydrazide-hydrazone and carboxamide moiety.
He H; Wang X; Shi L; Yin W; Yang Z; He H; Liang Y
Bioorg Med Chem Lett; 2016 Jul; 26(14):3263-3270. PubMed ID: 27262600
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel pyrano[3,2-c]carbazole derivatives as anti-tumor agents inducing apoptosis via tubulin polymerization inhibition.
Padmaja P; Koteswara Rao G; Indrasena A; Subba Reddy BV; Patel N; Shaik AB; Reddy N; Dubey PK; Bhadra MP
Org Biomol Chem; 2015 Feb; 13(5):1404-14. PubMed ID: 25467166
[TBL] [Abstract][Full Text] [Related]
13. Potent hydrazone derivatives targeting esophageal cancer cells.
Li LY; Peng JD; Zhou W; Qiao H; Deng X; Li ZH; Li JD; Fu YD; Li S; Sun K; Liu HM; Zhao W
Eur J Med Chem; 2018 Mar; 148():359-371. PubMed ID: 29475156
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of thiazole linked indolyl-3-glyoxylamide derivatives as tubulin polymerization inhibitors.
Guggilapu SD; Guntuku L; Reddy TS; Nagarsenkar A; Sigalapalli DK; Naidu VGM; Bhargava SK; Bathini NB
Eur J Med Chem; 2017 Sep; 138():83-95. PubMed ID: 28648953
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and bioevaluation and doking study of 1H-pyrrolo[2,3-b]pyridine derivatives bearing aromatic hydrazone moiety as c-Met inhibitors.
Wang W; Xu S; Duan Y; Liu X; Li X; Wang C; Zhao B; Zheng P; Zhu W
Eur J Med Chem; 2018 Feb; 145():315-327. PubMed ID: 29331754
[TBL] [Abstract][Full Text] [Related]
16. The design, synthesis and evaluation of selenium-containing 4-anilinoquinazoline hybrids as anticancer agents and a study of their mechanism.
An B; Zhang S; Hu J; Pan T; Huang L; Tang JC; Li X; Chan ASC
Org Biomol Chem; 2018 Jul; 16(25):4701-4714. PubMed ID: 29900452
[TBL] [Abstract][Full Text] [Related]
17. (E)-N-Aryl-2-oxo-2-(3,4,5-trimethoxyphenyl)acetohydrazonoyl cyanides as tubulin polymerization inhibitors: Structure-based bioisosterism design, synthesis, biological evaluation, molecular docking and in silico ADME prediction.
Wang G; Peng Z; Peng S; Qiu J; Li Y; Lan Y
Bioorg Med Chem Lett; 2018 Nov; 28(20):3350-3355. PubMed ID: 30197030
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of aminostilbene-arylpropenones as tubulin polymerization inhibitors.
Kamal A; Kumar GB; Polepalli S; Shaik AB; Reddy VS; Reddy MK; Reddy ChR; Mahesh R; Kapure JS; Jain N
ChemMedChem; 2014 Nov; 9(11):2565-79. PubMed ID: 25146959
[TBL] [Abstract][Full Text] [Related]
19. N-benzoxazol-2-yl-N'-1-(isoquinolin-3-yl-ethylidene)-hydrazine, a novel compound with antitumor activity, induces radicals and dissipation of mitochondrial membrane potential.
Hofmann J; Easmon J; Puerstinger G; Heinisch G; Jenny M; Shtil AA; Hermann M; Condorelli DF; Sciré S; Musumarra G
Invest New Drugs; 2009 Jun; 27(3):189-202. PubMed ID: 18612590
[TBL] [Abstract][Full Text] [Related]
20. YSL-12, a novel microtubule-destabilizing agent, exerts potent anti-tumor activity against colon cancer in vitro and in vivo.
Cai D; Qiu Z; Yao W; Liu Y; Huang H; Liao S; Luo Q; Xie L; Lin Z
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1217-29. PubMed ID: 27107592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
